Thrivent Financial for Lutherans’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$343K Buy
2023
Q3
Sell
2023
Q2
$2.63M Sell
2023
Q1
$5.93M Buy
2022
Q4
$3.53M Buy
2022
Q3
$4.08M Buy
2022
Q2
$3.77M Sell
2022
Q1
$4.72M Sell
2021
Q4
$5.69M Sell
2021
Q3
$6.37M Buy
2021
Q2
Sell
2021
Q1
$6.17M Buy
2020
Q4
$4.48M Buy
2020
Q3
$1.08M Buy